Postdoctoral Fellow-MSH

Mount Sinai Health System • New York, NY

5d

About The Position

Multiple postdoctoral positions are immediately available in Shi laboratory of Proteomics, Center for Protein Engineering and Therapeutics at Icahn School of Medicine at Mount Sinai in NYC The lab is interested in developing biotechnologies for the analysis of biomolecules and macromolecular assemblies, with a focus on mass spectrometry/proteomic techniques. Recently, inspired by the high translational potential of the camelid single-chain antibodies (so called nanobodies), our lab has developed robust pipeline technologies and tools to facilitate nanobody drug discovery and therapeutic applications. The lab is also interested in the development and application of integrative structural approaches to study protein-protein and antibody-protein interactions. An emerging direction of the lab is to conjugate machine learning, structural biology and proteomic approaches to facilitate engineering and design towards novel protein therapeutics and vaccine development. The lab is vibrant, fun, and collaborative and support creative ideas and career development. References: Kim, S.J., et al (2018). Integrative structure and functional anatomy of a nuclear pore complex. Nature. Xiang, Y., et al (2020). Versatile and multivalent nanobodies efficiently neutralize SARS-CoV-2. Science. Nambulli., et al (2021). Inhalable Nanobody (PiN-21) prevents and treats SARS-CoV-2 infections in Syrian hamsters at ultra-low doses. Science Advances. Xiang, Y., et al (2021). Integrative proteomics identifies thousands of distinct, multi-epitope, and high-affinity nanobodies. Cell Systems. Sun, et al. (2021). Potent neutralizing nanobodies resist convergent circulating variants of SARS-CoV-2 by targeting novel and conserved epitopes. Nature Communications. Shen et al. (2021). A resource of high-quality nanobodies for drug delivery. iScience. Sang, et al. (2021) Llamanade: an open-source computational pipeline for robust nanobody humanization. Structure. Xiang et al (2022). Super-immunity by broadly protective nanobodies to sarbecoviruses. BioRxiv. The lab is funded by multiple grants including the NIH, AAZ and MJFF. Competitive salaries can be provided for successful candidates. Visit our lab at: https://www.shi-lab.org/. Some related news are list here: Inhaled nanobodies effective against coronaviurs in hamsters, researchers say (Fox News) Llama 'nanobodies’ may yield COVID-19 treatment, Pitt scientists say (The Philadelphia Inquirer) Why the lovable llama might be a secret weapon against COVID-19 (Argonne National Library) https://pittnews.com/article/161919/top-stories/pitt-researchers-find-covid-19-breakthrough-in-llama-nanobodies/ https://www.upmc.com/media/news/052621-shi-duprex-pin21 https://www.innovation.pitt.edu/2020/11/antennabiotech/ https://www.upmc.com/media/news/021521-shi-massspecproteomics Nasal spray gives Pitt researchers a promising new weapon to fight COVID (Next Pittsburgh) Pitt Researchers Discover Llama ‘Nanobodies’ Are Powerful New Coronavirus Treatment (CBS Local) Pitt team discovers new way to find nanbodies to fight disease (WPXI) Pitt scientists unveil potential 'powerful' treatment for COVID-19 using llama nanobodies (WJAC) Pitt researchers say llamas may help research and treatment of COVID (WTAE) Alpacas and llamas may hold the key to alternative COVID-19 vaccine (Fox 8) Llama antibodies? Why researchers say they could be powerful weapon against COVID-19 (ABC 7) Researchers hope to harness power of llama nanobodies to treat coronavirus (Fox 43) Inhaled antibody fragments protect infected animals against COVID-19 (The Scientist) Inhalable nanobody shows potent anti-SARS-CoV2 activity in vivo (Medical.net) Scientists Cure COVID in Hamsters With Inhaled Nanobodies: Study (Gadgets 360) Llama nanobodes are a powerful bew COVID-19 treatment: Study (The New York Post) Asthma style inhalter of tiny nanobodies cleared COVID infection in hamsters (Daily Mail UK) Inhaled COVID Meds and 'Simple, Self-Administered' Care (Medscape) Neutralizing nanobodies effective against SARS-CoV2 variants (Medical.net)

Requirements

• Motivated individuals (PhD or MD) with a background in mass spectrometry-based proteomics, microbiology, structural biology (such as cryo-EM), and cancer immunology (ideally with animal model experience) are particularly welcome to apply.
• Interested candidates may submit their CV, including names and contact information for two-three references, a short description of their research experience, and goals to Yi Shi at ([email protected]).

What This Job Offers

• Job Type: Full-time
• Education Level: Ph.D. or professional degree
• Number of Employees: 5,001-10,000 employees